GSK Enters Agreement With U.S. Government to Lower Drug Prices and Expand Access to Respiratory Medicines for Millions of Americans
December 20, 2025
December 20, 2025
LONDON, England, Dec. 20 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release:
* * *
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
* Voluntary agreement delivers on all four of President Trump's requests and reduces the cost of medicines for Americans
* Includes products used to treat the more than 40 million p . . .
* * *
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
* Voluntary agreement delivers on all four of President Trump's requests and reduces the cost of medicines for Americans
* Includes products used to treat the more than 40 million p . . .
